These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38231001)

  • 1. The impact of forearm immobilization and acipimox administration on muscle amino acid metabolism and insulin sensitivity in healthy, young volunteers.
    Dirks ML; Jameson TSO; Andrews RC; Dunlop MV; Abdelrahman DR; Murton AJ; Wall BT; Stephens FB
    Am J Physiol Endocrinol Metab; 2024 Mar; 326(3):E277-E289. PubMed ID: 38231001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of short-term forearm immobilization and acipimox administration on muscle amino acid metabolism and insulin sensitivity in healthy, young volunteers.
    Dirks ML; Jameson TSO; Andrews RC; Dunlop MV; Abdelrahman DR; Murton AJ; Wall BT; Stephens FB
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Disuse and High-Fat Overfeeding on Forearm Muscle Amino Acid Metabolism in Humans.
    Wall BT; Cruz AM; Otten B; Dunlop MV; Fulford J; Porter C; Abdelrahman DR; Stephens FB; Dirks ML
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32303743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-fat Overfeeding Does Not Exacerbate Rapid Changes in Forearm Glucose and Fatty Acid Balance During Immobilization.
    Dirks ML; Wall BT; Otten B; Cruz AM; Dunlop MV; Barker AR; Stephens FB
    J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31609422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 3-hydroxybutyrate and free fatty acids on muscle protein kinetics and signaling during LPS-induced inflammation in humans: anticatabolic impact of ketone bodies.
    Thomsen HH; Rittig N; Johannsen M; Møller AB; Jørgensen JO; Jessen N; Møller N
    Am J Clin Nutr; 2018 Oct; 108(4):857-867. PubMed ID: 30239561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients.
    Nielsen S; Jørgensen JO; Hartmund T; Nørrelund H; Nair KS; Christiansen JS; Møller N
    Growth Horm IGF Res; 2002 Dec; 12(6):425-33. PubMed ID: 12423628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes.
    Saloranta C; Groop L; Ekstrand A; Franssila-Kallunki A; Eriksson J; Taskinen MR
    Diabet Med; 1993 Dec; 10(10):950-7. PubMed ID: 8306591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
    Bajaj M; Suraamornkul S; Romanelli A; Cline GW; Mandarino LJ; Shulman GI; DeFronzo RA
    Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
    Vaag A; Skött P; Damsbo P; Gall MA; Richter EA; Beck-Nielsen H
    J Clin Invest; 1991 Oct; 88(4):1282-90. PubMed ID: 1918378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.
    Segerlantz M; Bramnert M; Manhem P; Laurila E; Groop LC
    Eur J Endocrinol; 2003 Dec; 149(6):511-9. PubMed ID: 14640991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus.
    Davoren PM; Kelly W; Gries FA; Hubinger A; Whately-Smith C; Alberti KG
    Metabolism; 1998 Mar; 47(3):250-6. PubMed ID: 9500558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients.
    Piatti PM; Monti LD; Davis SN; Conti M; Brown MD; Pozza G; Alberti KG
    Diabetologia; 1996 Jan; 39(1):103-12. PubMed ID: 8720610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effect of decreasing nonesterified fatty acid levels with acipimox in hyperthyroid patients.
    Park KS; Kim CH; Lee MK; Shin CS; Park DJ; Kim SY; Cho BY; Lee HK
    Metabolism; 1999 Oct; 48(10):1318-21. PubMed ID: 10535397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial.
    Makimura H; Stanley TL; Suresh C; De Sousa-Coelho AL; Frontera WR; Syu S; Braun LR; Looby SE; Feldpausch MN; Torriani M; Lee H; Patti ME; Grinspoon SK
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1123-33. PubMed ID: 26691888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patients.
    Saloranta C; Groop L; Ekstrand A; Franssila-Kallunki A; Taskinen MR
    Acta Diabetol; 1994 Apr; 31(1):6-13. PubMed ID: 8043900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.
    Santomauro AT; Boden G; Silva ME; Rocha DM; Santos RF; Ursich MJ; Strassmann PG; Wajchenberg BL
    Diabetes; 1999 Sep; 48(9):1836-41. PubMed ID: 10480616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prolonged Acipimox treatment on glucose and lipid metabolism and on in vivo insulin sensitivity in patients with non-insulin dependent diabetes mellitus.
    Vaag AA; Beck-Nielsen H
    Acta Endocrinol (Copenh); 1992 Oct; 127(4):344-50. PubMed ID: 1449046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate.
    Fulcher GR; Walker M; Farrer M; Johnson AS; Alberti KG
    Metabolism; 1993 Mar; 42(3):308-14. PubMed ID: 8487648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults.
    Segerlantz M; Bramnert M; Manhem P; Laurila E; Groop LC
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5813-8. PubMed ID: 11739444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
    Kruszynska YT; Olefsky JM; Frias JP
    Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.